As companies strive to attract and retain top talent in a competitive market, expanding family building and reproductive care benefits emerges as a strategic approach. An increasingly significant aspect of this trend involves offering tailored benefits for employees undergoing menopause and perimenopause. The implications of such benefits span across several regulatory frameworks, including the Employee Retirement Income Security Act (ERISA) and the Affordable Care Act (ACA), necessitating careful consideration from employers.
Employers opting to provide menopause benefits often integrate these into existing health plans or establish separate Health Reimbursement Arrangements (HRAs). These benefits might encompass coverage for specialized physical therapy, access to menopause-specific medical practitioners, and discounts on medications used to alleviate menopause symptoms. When employers pay or reimburse medical expenses related to menopause, the arrangements typically qualify as group health plans under ERISA. However, establishing separate HRAs for menopause involves compliance with ACA market reforms and a range of other regulatory obligations.
Employers may also face challenges if their major medical plans, particularly those that are fully insured, do not permit the administration of dedicated menopause benefits. In such cases, separate HRAs could be configured to handle reimbursements independently. If HRAs are implemented, they must be structured to comply with ACA requirements, either as integrated HRAs or excepted benefit HRAs. Integrated HRAs require enrollment in an ACA-compliant plan, while excepted benefit HRAs have fewer regulatory requirements but are capped at $1,800 annually.
Additionally, federal statutes governing workplace accommodations and leave, such as the Americans with Disabilities Act (ADA) and the Family and Medical Leave Act (FMLA), may apply to employees experiencing severe menopause-related symptoms. While menopause, as a standard part of aging, does not automatically qualify as a disability under the ADA, specific symptoms that substantially limit major life activities might. Legal precedents, such as Mullen v. New Balance Athletics, underscore this nuanced applicability.
The Pregnant Workers Fairness Act (PWFA), effective from 2023, mandates workplace accommodations for pregnancy and related medical conditions, potentially including menopause under certain interpretations. The Equal Employment Opportunity Commission (EEOC) continues to refine guidance on whether menopause-related conditions fall under PWFA protection, advocating for case-by-case assessments.
Employers must also consider the implications under federal anti-discrimination and non-harassment laws. Menopausal status itself is not a protected characteristic; however, remarks or comments related to menopause can lead to claims of sex and age harassment, as illustrated in the EEOC’s 2024 workplace harassment guidance.
In conclusion, as companies prepare to implement menopause benefits, awareness of ERISA implications, ACA compliance, and broader legal considerations is essential. Employers should stay informed about evolving legislative and regulatory landscapes to effectively support their workforce while maintaining compliance.
For more detailed insights, refer to the original article by Jennifer Rigterink and Jurate Schwartz on Bloomberg Law.